Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.34 USD | +0.88% | +1.08% | +68.40% |
01/04 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
01/04 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.40% | 391M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.65% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09